Cargando…

Concomitant T-cell prolymphocytic leukemia and visceral leishmaniasis: A case report

RATIONALE: T-cell prolymphocytic leukaemia (T-PLL) is a rare aggressive lymphoid disease featured by a significant increased lymphocyte count and obvious hepatosplenomegaly with poor prognosis. The concomitant presentation of T-PLL and visceral leishmaniasis (VL) has not previously been reported. PA...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Hongyan, Jin, Yongmei, Yu, Jiang, Jiang, Nenggang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160114/
https://www.ncbi.nlm.nih.gov/pubmed/30235714
http://dx.doi.org/10.1097/MD.0000000000012410
_version_ 1783358702674247680
author Liao, Hongyan
Jin, Yongmei
Yu, Jiang
Jiang, Nenggang
author_facet Liao, Hongyan
Jin, Yongmei
Yu, Jiang
Jiang, Nenggang
author_sort Liao, Hongyan
collection PubMed
description RATIONALE: T-cell prolymphocytic leukaemia (T-PLL) is a rare aggressive lymphoid disease featured by a significant increased lymphocyte count and obvious hepatosplenomegaly with poor prognosis. The concomitant presentation of T-PLL and visceral leishmaniasis (VL) has not previously been reported. PATIENT CONCERNS: The patient initially suffered from anorexia, skin pigmentation, fever and hepatosplenomegaly. Bone marrow smear described leishmania and antibody test was positive. VL was diagnosed and he was given antimony gluconate therapy. His symptoms recurred. DIAGNOSIS: A combination of serological rk39 test, morphologic evaluation and immunophenotyping by flow cytometry finally supported the diagnosis of concomitant VL and T-PLL. OUTCOMES: Amphotericin B was used for the treatment of VL first and a referral for treating T-PLL after recovery from VL was suggested. Unfortunately, the patient requested to be discharged. Telephone follow-up indicated that he died a few days after leaving the hospital. LESSONS: Due to the rarity of the disease combination, the pathogenesis association of T-PLL and VL is unclear. However, a duly diagnosis is crucial for treatment. In immunosuppressed patients due to malignancies and treatment, VL should be considered as an opportunistic infection. In VL infections, the clinical manifestations mimicking hematological malignancies may cover up the underlying disease. Under such conditions, a complete work-up based on laboratory test is necessary to achieve a correct diagnosis.
format Online
Article
Text
id pubmed-6160114
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-61601142018-10-12 Concomitant T-cell prolymphocytic leukemia and visceral leishmaniasis: A case report Liao, Hongyan Jin, Yongmei Yu, Jiang Jiang, Nenggang Medicine (Baltimore) Research Article RATIONALE: T-cell prolymphocytic leukaemia (T-PLL) is a rare aggressive lymphoid disease featured by a significant increased lymphocyte count and obvious hepatosplenomegaly with poor prognosis. The concomitant presentation of T-PLL and visceral leishmaniasis (VL) has not previously been reported. PATIENT CONCERNS: The patient initially suffered from anorexia, skin pigmentation, fever and hepatosplenomegaly. Bone marrow smear described leishmania and antibody test was positive. VL was diagnosed and he was given antimony gluconate therapy. His symptoms recurred. DIAGNOSIS: A combination of serological rk39 test, morphologic evaluation and immunophenotyping by flow cytometry finally supported the diagnosis of concomitant VL and T-PLL. OUTCOMES: Amphotericin B was used for the treatment of VL first and a referral for treating T-PLL after recovery from VL was suggested. Unfortunately, the patient requested to be discharged. Telephone follow-up indicated that he died a few days after leaving the hospital. LESSONS: Due to the rarity of the disease combination, the pathogenesis association of T-PLL and VL is unclear. However, a duly diagnosis is crucial for treatment. In immunosuppressed patients due to malignancies and treatment, VL should be considered as an opportunistic infection. In VL infections, the clinical manifestations mimicking hematological malignancies may cover up the underlying disease. Under such conditions, a complete work-up based on laboratory test is necessary to achieve a correct diagnosis. Wolters Kluwer Health 2018-09-21 /pmc/articles/PMC6160114/ /pubmed/30235714 http://dx.doi.org/10.1097/MD.0000000000012410 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Research Article
Liao, Hongyan
Jin, Yongmei
Yu, Jiang
Jiang, Nenggang
Concomitant T-cell prolymphocytic leukemia and visceral leishmaniasis: A case report
title Concomitant T-cell prolymphocytic leukemia and visceral leishmaniasis: A case report
title_full Concomitant T-cell prolymphocytic leukemia and visceral leishmaniasis: A case report
title_fullStr Concomitant T-cell prolymphocytic leukemia and visceral leishmaniasis: A case report
title_full_unstemmed Concomitant T-cell prolymphocytic leukemia and visceral leishmaniasis: A case report
title_short Concomitant T-cell prolymphocytic leukemia and visceral leishmaniasis: A case report
title_sort concomitant t-cell prolymphocytic leukemia and visceral leishmaniasis: a case report
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160114/
https://www.ncbi.nlm.nih.gov/pubmed/30235714
http://dx.doi.org/10.1097/MD.0000000000012410
work_keys_str_mv AT liaohongyan concomitanttcellprolymphocyticleukemiaandvisceralleishmaniasisacasereport
AT jinyongmei concomitanttcellprolymphocyticleukemiaandvisceralleishmaniasisacasereport
AT yujiang concomitanttcellprolymphocyticleukemiaandvisceralleishmaniasisacasereport
AT jiangnenggang concomitanttcellprolymphocyticleukemiaandvisceralleishmaniasisacasereport